anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 233,731-233,760
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

233,731-233,760 of 303,780

filter-aware
06
The slide uses a circular flywheel diagram to explain the business model's compounding value.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Early Struggles1 hit
07
The slide uses a before/after visual comparison of the part structure alongside a bar chart for performance validation.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
08
The slide uses a hub-and-spoke process flow to explain the platform's value proposition.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
09
The slide uses a timeline-based layout to showcase product evolution from 2016 to 2024.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
10
Markforged | Results Presentation Deck | 21 slidesMarkforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Rising Success1 hit
11
The slide uses a logo-grid layout categorized by industry.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Rising Success1 hit
12
The slide uses a central product image with callouts pointing to specific features.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
13
The slide uses a before/after style logic to present the ROI and cost savings.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
14
The slide uses a linear process flow diagram to represent growth drivers.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
15
The slide uses a grid layout to display 11 executive profiles.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · The Breakthrough1 hit
16
The slide uses a grouped bar chart format to compare year-over-year performance for each quarter.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · The Breakthrough1 hit
17
The slide uses a dark theme with yellow and white bars to distinguish between 2022 and 2023 data.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
18
The slide uses a dark background with yellow text for key metrics. It includes specific disclaimers regarding non-GAAP reporting and revenue guidance basis.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
19
Includes a footnote explaining the composition of non-recurring costs for both years.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
20
Includes footnote detailing non-recurring costs.Markforged | Results Presentation Deck | 21 slides · Markforged
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
01
Slide 1
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
02
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
03
The slide uses a process-flow structure to connect the technology (LNCs) to current clinical validation (MAT2203) and future pipeline expansion.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
04
Includes scientific illustration of molecular structure and bulleted list of key benefits.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
05
The slide uses a two-part framework to explain the biological mechanism: Targeting (left) and Delivery (right).Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
07
Uses authority-citation to establish the urgency of the problem.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
This is a validation slide showing scientific credibility through peer-reviewed publication.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
11
The slide uses a human silhouette as a central anchor to map specific medical conditions to anatomical locations.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
12
Highlights clinical success in patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
13
Includes a timeline of clinical events and longitudinal charts for Creatinine and Potassium levels.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
14
The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
Mentions specific regulatory pathways (LPAD, QIDP, ODD, Fast-Track) and the ORALTO trial.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The slide outlines a non-inferiority trial design comparing oral MAT2203 to IV LAMB/SoC.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
17
Uses a combination of an additive equation for the value prop and a chevron-based timeline for lifecycle management.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide uses a process-flow style diagram to map delivery mechanisms to therapeutic areas.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit